Ergothioneine Derivative Composition for Hydrogen Peroxide Removal
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for new hydrogen peroxide removers and cytotoxicity inhibitors that can effectively address a wide variety of uses and targets requiring these effects.
Innovation Solution
A novel ergothioneine derivative, represented by a specific compound or its salt, is produced through a heat-treatment process, which can be used in compositions to act as a hydrogen peroxide remover and cytotoxicity inhibitor.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional hydrogen peroxide removers and cytotoxicity inhibitors are used, then existing functions are maintained, but the variety of uses and targets is limited
Solution Approach 1:
The patent applies universality by developing a novel ergothioneine derivative that serves multiple functions as both a hydrogen peroxide remover and a cytotoxicity inhibitor. This single compound can be applied to various uses and targets, expanding adaptability while maintaining reliable effectiveness across different applications through its dual functional capabilities
2Adaptability or versatility
If new hydrogen peroxide removers and cytotoxicity inhibitors are developed, then adaptability and versatility are improved, but development complexity increases
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of ergothioneine to create a novel derivative with enhanced functionality. By changing molecular parameters (adding specific functional groups or modifying existing structures), the invention achieves greater versatility in hydrogen peroxide removal and cytotoxicity inhibition while managing development complexity through systematic structural modification
3Reliability
If heat treatment is applied to L-ergothioneine at 60°C or more for 24 hours or more, then the novel derivative is produced, but energy consumption and processing time increase
Solution Approach 1:
The patent applies phase transitions by utilizing heat treatment to induce thermal transformation of L-ergothioneine into the novel derivative. The controlled heating process (60°C or more for 24 hours or more) triggers a chemical phase transition that produces the desired product, accepting energy consumption and processing time as necessary costs to achieve reliable production of the novel compound
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The ergothioneine derivative effectively removes hydrogen peroxide and reduces cytotoxicity caused by it, demonstrating efficacy in reducing cytotoxicity in a medium.
Implementation Method 1
a step (1) for heat-treating an aqueous solution of L-ergothioneine at 60°C or more for 24 hours or more
Implementation Method 2
The ergothioneine derivative effectively removes hydrogen peroxide and reduces cytotoxicity caused by it
Data Source
Figure 1~2
Figure 3
Figure 4~5
AI summary
Provided are a novel ergothioneine derivative and a method for producing the same; a composition containing the derivative; a hydrogen peroxide remover, and a cytotoxicity inhibitor. A compound represented by the following formula (1) or a salt thereof.